Webinar: The Importance of Small Airways in Asthma. Sponsored by Chiesi Ltd.
This promotional session has been organised and funded by Chiesi Ltd.
Webinar Details
This session has been organised and funded by Chiesi Ltd. This session contains promotional content and is intended for UK Healthcare Professionals Only.
The Importance of Small Airways in Asthma
Wednesday 4th March, 1pm - 2pm
Key takeaways:
- To understand the role of the small airways in asthma and their importance as a therapeutic target for improving patient outcomes.
- To identify patients with asthma who may benefit from triple therapy to optimise symptom control and overall management.
- To understand and apply the principles of how triple therapy works to provide improved symptom relief.
Speaker:
Monbi Stefanova Chakma, Clinical Pharmacist
Chair:
Nazir Hussain, Specialist Respiratory Pharmacist and PCPA Regional Ambassador, Midlands
Speaker
Monbi Stefanova Chakma
Monbi Stefanova Chakma is a clinical pharmacist and final year PhD candidate at the National Heart and Lung Institute (NHLI), Imperial College London. She qualified as a pharmacist from King’s College London, during which she collaborated with researchers at Keimyung University, South Korea and industry partners at Intertek, focusing on drug delivery devices and inhalable formulations. Her PhD integrates patient physiology and psychology in the development of inhaler devices, with a particular focus on dry powder inhalers and the impact of airflow resistance. This work is conducted in collaboration with the University of Hertfordshire and is supported by the U.S. Food and Drug Administration.
Monbi has showcased her research at leading conferences in the respiratory field, where she has also chaired sessions on inhaler technology (e.g. Drug Delivery to the Lungs 2019, European Respiratory Society 2022-2024, International Society for Aerosols in Medicine 2023-2025).
